Overview

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
This study is to determine whether a medication on the market for other indications is effective and safe in treating seborrheic dermatitis of the face.
Phase:
Phase 2
Details
Lead Sponsor:
Bayer
LEO Pharma
Collaborator:
Bayer
Treatments:
Azelaic acid